Bouwer, Nathalie I <br/><br/>
Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice.  [electronic resource] 

 -  Breast (Edinburgh, Scotland)  Aug 2020 
 - 33-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1532-3080 
<br/><br/><label>Standard No.: </label>10.1016/j.breast.2020.04.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Biomarkers--blood<br/>Breast Neoplasms--drug therapy<br/>C-Reactive Protein<br/>Cardiotoxicity--diagnostic imaging<br/>Echocardiography--methods<br/>Echocardiography, Three-Dimensional--methods<br/>Female<br/>Humans<br/>Immunoglobulin E<br/>Incidence<br/>Interleukin-1 Receptor-Like 1 Protein<br/>Natriuretic Peptide, Brain<br/>Peptide Fragments<br/>Peroxidase<br/>Receptor, ErbB-2--metabolism<br/>Trastuzumab--therapeutic use<br/>Troponin<br/>Ventricular Dysfunction, Left--chemically induced